tyrosine Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (11)

Phase 1/2 (1)
Phase 3 (8)
Unknown (2)

Interventional (10)
Observational (1)

Sanofi (7)
Huiqiang Huang (1)
Nantes University Hospital (1)
The First Affiliated Hospital of Zhengzhou University (1)
Yuhan Corporation (1)

No (11)

No (11)

Adult (18+) (11)

I am/have/had

I am/have/hadEGFR

I am/have/hadebv-positive dlbcl, nos

I am/have/hadfollicular lymphoma grade iiib

I am/have/hadhigh-grade lymphoma

I am/have/hadpulmonary function test

I am/have/hadcreatinine clearance rate

I am/have/hadneutrophil count

I am/have/hadserum pregnancy test

I am/have/hadmultiple sclerosis

I am/have/hadaptt

I am/have/hadglioma

I am/have/hadfollicular lymphoma

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadtyrosine

I am/have/hadct scan

I am/have/hadhypertension

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadvascular endothelial growth factor

I am/have/hadblood transfusion

I am/have/hadvegf

added new label for I am/have/had

more

I am looking for

I am looking for18f-fdg

I am looking forhmr1726

I am looking fororal contraceptives

I am looking forapatinib

I am looking forgefitinib

I am looking forcamrelizumab

I am looking forg-csf

I am looking forgrowth factor

I am looking foraubagio

I am looking forcolony stimulating factor

I am looking forgranulocyte colony stimulating factor

I am looking foranticoagulants

I am looking fortyrosine

I am looking forteriflunomide

I am looking forlazertinib

I am looking forvascular endothelial growth factor

I am looking forvegf

I am looking forrituximab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 11 clinical trials

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2). This study aims to collect clinical, radiological and histopathology imaging including detailed radiological data, survival data, clinical parameters, molecular pathology and images of HE slices …

neutrophil count

growth factor

glioma

liver metastasis

tyrosine

0 views
19 Feb, 2024

1
2

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.